Phase 1 Study for Safety and Tolerability of IL-1-Ra Topically Administered to Eyes of Healthy Adult Subjects
Clinical trial NCT03383276 · UNKNOWN
Trial details
- NCT number
- NCT03383276
- Sponsor
- Beijing Tongren Hospital
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-18
- Primary completion
- 2018-03-25
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.